🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.32472
+0.00082 (0.25%)
At close: Nov 20, 2026

Elite Pharmaceuticals Revenue

Elite Pharmaceuticals had revenue of $40.08M in the quarter ending September 30, 2026, with 10.35% growth. This brings the company's total for the last twelve months to $144.77M, up 17.81% year-over-year. In the fiscal year ending March 31, 2026, Elite Pharmaceuticals had annual revenue of $148.87M with 77.13% growth. That makes Elite Pharmaceuticals the 19,925th largest company in the world by revenue and 3,066th in the United States.

Revenue (ttm)
144.77M
Revenue Growth
+17.81%
P/S Ratio
2.42
Revenue / Employee
2.23M
Employees
65
Market Cap
349.88M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2026148.87M64.83M77.13%
Mar 31, 202584.04M27.42M48.42%
Mar 31, 202456.63M22.47M65.79%
Mar 31, 202334.16M1.89M5.87%
Mar 31, 202232.26M6.88M27.11%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Sofgen Pharma373.80M
Eagle Pharmaceuticals257.55M
MariMed167.28M
Earth Science Tech34.21M
Radnostix10.52M
Healthy Extracts5.99M
Bio Essence3.03M
Revenue Rankings